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A B S T R A C T   
Enteropathogenic E. coli (EPEC) causes intestinal infections leading to severe diarrhea. EPEC attaches to the host 
cell causing lesions to the intestinal epithelium coupled with the effacement of microvilli. In the process, actin 
accumulates into a pedestal-like structure under bacterial microcolonies. We designed an automated fluorescence 
microscopy-based screening method for discovering compounds capable of inhibiting EPEC adhesion and viru-
lence using aurodox, a type three secretion system (T3SS) inhibitor, as a positive control. The screening assay 
employs an EPEC strain (2348/69) expressing a fluorescent protein and actin staining for monitoring the bacteria 
and their pedestals respectively, analyzing these with a custom image analysis pipeline. The assay allows for the 
discovery of compounds capable of preventing the formation of pathogenic actin rearrangements. These com-
pounds may be interfering with virulence-related molecular pathways relevant for developing antivirulence 
leads.   
1. Introduction 
Gastrointestinal infections and diarrheal diseases are pervasive 
global health burdens, especially with ever-increasing levels of antimi-
crobial drug resistance (Fagundes-Neto, 2013). One considerable cause 
of diarrhea and intestinal infections is enteropathogenic Escherichia coli 
(EPEC), which exhibits resistance to a large range of antibiotics 
(Rodrigues, 2019; Eltai et al., 2020). Treating resistant gastrointestinal 
infections with antibiotics is particularly problematic because antibi-
otics also target protective normal flora, while possibly not eliminating 
resistant pathogens. As a consequence, an extensive amount of research 
has been put forward to develop so-called antivirulence drugs, that is, 
drugs capable of attenuating virulence, without eliminating bacteria 
(see Dickey et al., 2017 for review). Approved antivirulence drugs to 
date are compounds attenuating the effects of toxins, but preclinical 
research has also focused at other possible targets, such as various 
attachment adhesins and appendices, cell-to-cell communication 
(quorum sensing), inhibition of specialized bacterial secretory systems, 
and virulence gene expression (Buroni and Chiarelli, 2020; Theur-
etzbacher et al., 2020). 
The virulence of EPEC, and many other human enteric pathogens is 
brought about by manipulating pathways of membrane trafficking, cell 
death/survival and the modulation of the cytoskeleton, ultimately 
altering the macroscopic properties of the epithelium and provoking 
gastroenteritis (Mattoo et al., 2007). So-called effector proteins (viru-
lence factors) are used by EPEC and most Gram-negative pathogens to 
achieve these effects. Effector proteins are injected into the host cell 
using the type three secretion system (T3SS), a needle-like injection 
appendage and associated effectors (Gophna et al., 2003). The effectors 
are typically carried through the needle by chaperones to the cytosol 
where they play various roles, often aiding the pathogen in invading the 
host and surviving host defense mechanisms. The size of the ensemble of 
secreted effectors varies between pathogens, from the four of Pseudo-
monas aeruginosa to several hundred in other pathogens (Lee et al., 
2005). Due to the near universality of the T3SS, research has targeted 
this system in attempts to discover drugs capable of attenuating viru-
lence without antibiotic mechanisms of action (Baron, 2010). The most 
advanced demonstration of the therapeutic usefulness of T3SS inhibition 
has been a phase 2 trial of an antibody for Pseudomonas aeruginosa in-
fections by KaloBios Pharmaceuticals (Jain et al., 2018). 
In typical presentations of EPEC infection, the bacterium adheres to 
intestinal epithelium, causing the localized effacement of microvilli, the 
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abnormal polymerization of actin in its vicinity, and increasing the 
permeability of the epithelium (Moon et al., 1983). Initially EPEC ad-
heres to cells using multiple appendices (e.g. pili) forming localized 
bacterial aggregates or microcolonies. This phenotype was named 
localized adherence by Scaletsky and colleagues (Scaletsky et al., 1984). 
After the initial stage of adherence, EPEC injects virulence molecules 
with the T3SS into the host causing the bacteria to adhere more vigor-
ously and initiate the formation of A/E lesions (Moon et al., 1983). The 
damage leads to the retention of water and the malabsorption of nutri-
ents and therefore to diarrhea and other symptoms. While the time 
frame of the onset of symptoms suggests that changes in chloride ion 
secretion are the de facto main cause of acute diarrhea (Lapointe et al., 
2009), A/E lesions and the associated actin pedestals are considered to 
be important facets of the illness allowing for chronic infections lasting 
up to 30 days (Fagundes-Neto and Scaletsky, 2000). 
Our assay focuses on the fact that EPEC effectors manipulate the 
cytoskeleton, inducing so-called actin pedestals, protrusions of 
abnormal actin polymerization. While the exact function of actin ped-
estals is unknown, they may be a form of niche construction and func-
tion to protect the pathogen from environmental stress, for example 
shear within the intestines, and host immune responses such as phago-
cytosis (for discussion on theories of possible function see, for example 
Battle et al., 2014; Brady, 2007; Cepeda-Molero et al., 2020). Com-
pounds or structural motifs capable of altering the actin polymerization 
phenotypes caused by bacterial pathogens, could be used as starting 
points for the development of antivirulence drugs especially since 
deletion mutants lacking some of the effectors involved tend to show 
either attenuated virulence or the lack of it entirely. For example, the 
deletion of EPEC eae – a gene encoding a C-lectin adhesin intimin, 
expressed on the bacterial outer membrane and responsible for binding 
to a translocated receptor, Tir – produces mutants incapable of forming 
pathogenic actin rearrangements and showing decreased adhesion in 
cell culture models (Cleary, 2004), although in cultured human biopsies 
other effectors are also required (Cepeda-Molero et al., 2017). Similarly, 
the deletion of espA, a gene encoding one of the main structural proteins 
of the T3SS appendage, produce mutants showing decreased adhesion to 
cells (Cleary, 2004). 
To our knowledge, high-throughput assays monitoring pathogen- 
induced actin rearrangements have not been reported before. We 
therefore designed a high-content fluorescence-based imaging assay 
using the previously described fluorescent actin staining assay (Knutton 
et al., 1989), a fluorescent EPEC strain, and readily available license-free 
image analysis software. This assay is capable of assessing the capacity 
of compounds to inhibit A/E lesion-associated actin rearrangement. 
2. Materials and methods 
2.1. Assay design 
The overall workflow of the assay is shown in Fig. 1. The assay in its 
entirety can be run in two days, where the first day is required for 
preparation of cell and bacterial cultures. On the second day the infec-
tion, staining, and imaging are done. After the plates are fixed, they can 
be stored without considerable degradation for at least a week in the 
dark at +4 ◦C until imaging is performed. 
2.1.1. Creation and validation of the fluorescent bacterial strain 
Escherichia coli 2348/69, a typical EPEC type 1 strain, was obtained 
from Reference Microbiology Services, UK. Liquid overnight cultures 
were grown in LB broth at 37 ◦C and 200 rpm from single colonies taken 
from a weekly renewed LB agar culture. For image acquisition, the strain 
was transformed with a plasmid to constitutively express fluorescent 
protein mCherry. To achieve this, competent bacteria were made using 
the rubidium chloride method (Bird, 2011). The plasmid pON.mCherry, 
Addgene #84821 deposited by Howard Schuman (Gebhardt et al., 
2017), was extracted using a miniprep kit (GeneJET, Thermo Fisher 
Scientific K0502). After this, the extracted plasmid was incubated with 
the competent bacteria and the transformants were selected with 30 μg 
mL− 1 chloramphenicol and deposited into long-term storage (− 80 ◦C) as 
glycerol stocks. 
To assess stability of the fluorescent strain, we proliferated and 
incubated the transformed bacteria in conditions identical to those used 
in the assay. After pre-incubation in MEM, 100 μL suspensions (2 × 106 
cfu mL− 1) of bacteria were placed into an empty imaging 96-well plate 
Fig. 1. The assay workflow. On the first day, 
Caco-2 cells are seeded to a well plate while 
an overnight liquid culture is initiated from 
the glycerol stock of the bacteria. The 
following day, bacteria are first preincubated 
in serum-free MEM for three hours and used 
to infect the cells. The cells are then incu-
bated with the bacteria for two hours and 
exposed to test compounds or the aurodox 
control. The infection is terminated by add-
ing the fixative-containing staining solution, 
after which the plate is imaged, and the im-
ages processed.   
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(Viewplate, Perkin Elmer) where they were imaged with phase contrast 
and fluorescence microscopy at 20×. The resulting images were pro-
cessed principally following the ideas described by Canny (1986) and 
enumerating the individual bacteria in both the phase contrast and the 
fluorescence image to estimate the proportion of fluorescent bacteria in 
the population. 
To demonstrate that the transformed EPEC strain pertained patho-
genicity, we infected the cells with the transformed strain and the wild 
type side-by-side using antibodies to visualize the non-fluorescent bac-
teria. Cells infected with non-fluorescent wild type bacteria were first 
washed three times with Hank’s Balanced Salt solution (HBSS), and 
fixed in 4% paraformaldehyde for ten minutes. The cells were then 
washed thrice with PBS and blocked using 1% bovine serum albumin 
(Merck) for one hour. After this, the cells were permeabilized with 0.1% 
(v/v) Triton X-100 and 1% (w/v) BSA in PBS for three minutes and 
washed thrice with PBS. Next, the samples were incubated with E. coli 
serotype O/K polyclonal antibody (PA1-73032, Thermo Fisher Scienti-
fic) 1:100 and 1% BSA for two hours. The cells were washed thrice with 
PBS, then incubated with Rabbit anti-goat IgG (H + L) Cross-Adsorbed 
antibody conjugated to AlexaFluor-594 (Thermo Fisher Scientific) 
1:1000 and 1% BSA, for one hour, and washed with PBS thrice. For the 
analysis of F-actin, AlexaFluor-488-conjugated phalloidin (Thermo 
Fisher Scientific) was applied (20 pM) for 20  min and for nuclei Hoechst 
333432 (Merck) (3 μg/mL) for three minutes. Then cells were washed 
three times with PBS before imaging. All these steps were performed at 
room temperature. 
2.1.2. Infection of mammalian cells 
Human epithelial colorectal adenocarcinoma Caco-2 cells (ATCC 
HTB-37) were maintained in Minimal Essential Medium (MEM) sup-
plemented with 10% fetal bovine serum (FBS), 1% L-glutamine and 1% 
non-essential amino acids at 37 ◦C, 95% humidity and 5% CO2. All cell 
culture reagents were obtained from Thermo Fisher Scientific. 
The infection of Caco-2 cells was performed essentially as described 
previously (Cravioto et al., 1979; Knutton et al., 1989). The cells were 
seeded onto poly-D-lysine (Merck) coated, black, clear bottom 96-well 
plates (Viewplate, Perkin Elmer) at 4 × 104 cells per well and incu-
bated for 24 h before the infection. Overnight bacterial liquid cultures 
were proliferated directly from the glycerol stocks, by cultivation in 
sterile glass tubes in LB broth supplemented with 30 μg mL− 1 chlor-
amphenicol at 37 ◦C, 200 rpm. Bacteria were then preincubated as 
described previously (Vuopio-Varkila and Schoolnik, 1991) in a 
nutrient-deficient medium (MEM without serum) to promote the 
expression of virulence factors including bundle forming pili (Vuopio- 
Varkila and Schoolnik, 1991) and locus of enterocyte effacement (LEE) 
gene products (Hazen et al., 2017). Liquid overnight cultures were 
diluted 1:50 in serum-free MEM and placed for three hours at 37 ◦C 
without shaking in a centrifuge tube with filter cap (Corning mini 
bioreactor 431,720). At this point, we also added the positive control, 
aurodox (1–10 μg mL− 1) (BioVision), into one of the bioreactors. Finally, 
the preincubated bacteria were added to the well plates at a multiplicity 
of infection (MOI) of 1:10 suspended in serum-free MEM. The plates 
were centrifuged (Eppendorf 5840R) for four min at 1000 ×g for the 
synchronization of the infection, and subsequently incubated for two 
hours at 37 ◦C and 5% CO2. 
2.1.3. Fluorescence staining 
Cells infected with the mCherry-expressing EPEC were fixed and 
stained following a protocol published earlier (Knutton et al., 1989), 
with slight modifications to make it more amenable for high-throughput 
assays. An equivalent volume (100 μL) of staining solution [8% para-
formaldehyde, 0.2% Triton-X (Thermo Fisher Scientific), 40 pM 
phalloidin-AlexaFluor-488 (Thermo Fisher Scientific), 6 μg/mL Hoechst 
33342 (Thermo Fisher Scientific) in PBS] was added directly to the in-
cubation medium for 20 min. The cells were washed three times with 
HBSS before imaging. 
2.1.4. Imaging 
After the cells were infected and stained as described above, they 
were imaged using Cytation 5 (BioTek) with 20× Plan Fluorite phase 
contrast NA 0.45 objective (Olympus 1,320,517) and filter cubes for 
DAPI (1225100) to visualize Hoechst 33342, Texas red (1225102) to 
visualize mCherry and GFP (1225101) to visualize AlexaFluor-488. 
Focal plane stacks of 20 images with distance 0.8 μm of each other 
were taken from five non-overlapping fields of view within each well. 
The locations of these were the same for each well as the microscope 
does not allow imaging at random locations. A stack of focal planes and 
their projection was used to ensure capturing in-focus actin pedestal 
images over the entire field of view as the pedestals are not always 
entirely on the same z-plane. We used three of the images from the stack 
for the projection, the rest of the – mostly out-of-focus – stack images 
were excluded from the analysis. Taking such excessive image stacks is 
due to a limitation of the imager, which does not allow to take a focal 
plane stack of three images from different focal points for the three 
different channels separately. Data was reduced from all five fields of 
view and an arithmetic mean was calculated to represent the data for a 
particular well. More than one field allows for a better estimate of the 
well-level effect and also protects against failures in image acquisition as 
the probability of one image capture failing is substantially larger than 
that of five independent captures. 
2.1.5. Image preprocessing and analysis 
The raw images were preprocessed and analyzed using scikit-image 
0.17 (van der Walt et al., 2014). The preprocessing stage consists of 
an algorithm which estimates the quality of the images before pro-
ceeding to the analysis. This includes the estimation of the degree to 
which cells occupy each field of view (confluency of the monolayer) and 
evaluates how well the autofocus algorithm of the microscope worked. 
Confluency is estimated by comparing the total image pixel count to the 
actin-stained areas that can display fluorescence signal, as this ap-
proaches 100% when there is an intact monolayer over the entire image. 
Bacteria bind to the plate giving misleading readouts if there are areas 
void of cells, since they cannot cause actin pedestals there. Similarly, 
out-of-focus images are detected by the “variance of the Laplacian”- 
method from the bacterial signal (International Conference on Pattern 
Recognition et al., 2000). Sometimes the autofocus algorithm of the 
imager would focus on a floating detached cell or debris or fail for no 
obvious reason. The captured image is convolved with a 10 × 10 Lap-
lacian kernel to acquire the second derivative of the image and the 
variance of the transform is measured. Properly focused images gener-
ally have higher variance because of sharp contrasts, whereas images 
with issues in focus, such as blur, will have lower than expected values. 
Low quality images were then flagged and automatically removed, as 
they were rare events. Low quality was defined as either more than 10% 
of the image missing cells or a variance of the Laplacian more than three 
standard deviations from the mean. When an image was rejected in this 
manner, it meant that the well-level data was produced by averaging 
only four, and not five, fields of view for one well. In other words, no 
well level data was deleted or marked as an outlier as is often done in 
screening. 
A set of features was extracted from the preprocessed images. The 
microcolony counts were extracted by first uncovering a threshold value 
via Otsu’s method, which minimizes interclass intensity variance for 
signal and background (Otsu, 1979). Subsequently, this threshold value 
was used to create a binary (foreground/background) mask, which was 
then used for labeling all connected components from the bacterial 
signal with a Union Find algorithm and counting each object (Fiorio and 
Gustedt, 1996)(depicted in Fig. 2A). 
To enumerate the pedestals, we applied the created binary mask to 
the image of the actin staining captured from the equivalent location to 
define regions of interest (Fig. 2B) and saved them as individual images 
(examples in Fig. 2C). These collections of segments from each field of 
view were then subjected to further analysis, where contours were 
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searched for from within them by tracking the most intense pixels by 
another round of segmentation (Fig. 2C). This is based on the notion that 
actin pedestals are excessive polymerization of actin, which would lead 
to higher local concentrations of the fluorophores. If these secondary 
segments from within the primary segments were co-located with a 
microcolony – that is they also had higher than threshold fluorescence 
from the equivalent region in the bacterial signal – they were kept and 
counted as pedestals, otherwise they were discarded as artifacts or other 
actin condense structures not related to bacteria. After summing up all 
the colonies and pedestals in this way, they were combined into a 
descriptive proportion number ̂p(x), by dividing the amount of pedestals 
(all segments, si that meet the conditions x for being a pedestal) by the 







In addition, we measured bulk fluorescence, microcolony size and 
density of the pedestals, estimated by computing the distance from the 
minimum to maximum intensity within the saved individual images 
(shown in Fig. 2C). 
Plotting was performed using the graphing tool, GR with the Stats-
Plots library of Julia, and scientific color maps (Crameri, 2019). Statis-
tics were calculated with libraries of Julia 1.6 (Bezanson et al., 2017). 
2.1.6. Selection of the positive control 
The assay protocol was executed as described above (see 2.1) while 
various candidate compounds were added in a range of concentrations 
(Table 1). Aurodox was administered in advance as explained above (see 
2.1.2) while other substances were administered to the bacteria upon 
infecting the cells. For selection we used a random intercept and random 
slope linear mixed effects model to detect any monotonic concentration- 
dependent response and evaluate the intraclass correlation of the mea-
surements within the experiments. As selection criteria we used the 
Fig. 2. Image processing methods. A) First, a mask is created from the fluorescence signal emitted by the bacteria (mCherry). The mask is shown in red and cor-
responds to the areas where the microcolonies are located. B) Then the equivalent regions are cut out from the actin signal in the primary segmentation step 
(phalloidin stained image). C) Lastly, secondary segmentation is performed within the collected primary segments, here marked with a blue bounding box. Images 
classified Y = pedestal, N = not, d = dense as described in section 2.1.5. These images are cropped for presentation. (For interpretation of the references to color in 
this figure legend, the reader is referred to the web version of this article.) 
Table 1 
Compounds considered as positive controls for the assay.  












recombinant, (rice), iron 
saturated, ≥90% (Ochoa 
et al., 2003) 





peptide (YFPYSHTSPRQP) ( 
Li et al., 2016) 
50–200 μg 
mL− 1 
blocking of EspB Merck 
genistein 16–67 μg mL− 1 kinase inhibitor Merck  
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model slope and between-experiment variability (Supplementary data 
Table S1). 
2.2. Assay validation 
2.2.1. DMSO tolerance 
As library compounds are often stored and administered to assays in 
DMSO, an experiment was carried out to assess the effects of DMSO on 
assay readouts. The assay protocol was executed as described above (see 
2.1). Various concentrations (1–10%) of DMSO were added into the 
bacterial suspension for the duration of the infection. 
2.2.2. Aurodox tolerance 
Because the positive control was reported to have antimicrobial ef-
fects (Kimura et al., 2011; Maehr et al., 1979), an experiment was car-
ried out to assess its capacity to inhibit bacterial growth. Bacteria were 
grown overnight and preincubated as described in 2.1.2. A suspension of 
about 4 × 106 bacteria /mL was prepared into fresh LB broth with 
chloramphenicol, dispensed into a white 96-well plate (100 μl/well) and 
exposed to different concentrations (2.5–10 μg mL− 1) of aurodox, to LB 
as a non-treated control and to 70 μg mL− 1 streptomycin sulfate. After 
two hours, bacterial titer was assessed with an ATP-based kit BacTiter- 
Glo (Promega) measuring luminescence for 1000 ms on Varioskan 
LUX (Thermo Fisher Scientific). 
2.2.3. Assay reproducibility 
To evaluate the reproducibility of the assay between distinct days 
and variation between the wells within one individual plate, we fol-
lowed the Assay Guidance Manual (Iversen et al., 2004). The assay was 
performed on three separate days by plating a maximal concentration 
(5.0 μg mL− 1) of the positive control aurodox, a lower concentration 
(2.5 μg mL− 1), and non-treated control at varying locations on the plate. 
After incubation, these plates were stained, imaged and analyzed as 
described above (see 2.1). We used Z’ and Signal Window (SW) as effect 
size and variance metrics to assess the responses of the screening assay: 
















where μmax is the arithmetic mean of the high value sample (no inhi-
bition) and μmin is the low value sample mean, σ is the sample standard 
deviation. 
3. Results and discussion 
In past years, traditional target-based high-throughput screening 
(HTS) for antimicrobials has been essentially unsuccessful. An analysis 
of 70 HTS campaigns conducted towards essential genes of bacteria at 
GlaxoSmithKline during 1995–2001 described an end result of no 
workable drug candidates (Payne et al., 2007). A similar later analysis 
(2001− 2010) of 65 HTS campaigns by AstraZeneca also failed to pro-
duce any (Tommasi et al. 2015). The authors of the later paper opinion 
that among other things, such campaigns utilize very reductionist assays 
uncovering active structures either not being capable of entering bac-
teria or being effluxed by membrane pumps. 
Issues such as this have led to increased interest in whole-cell assays 
where the critical capacity of compounds to reach the target is assessed 
already during screening. For example, in the absence of any known 
shared molecule to target with ligand-based design, multiple whole-cell 
screening assays have analyzed phenotypic changes to uncover small 
molecule T3SS-inhibitors, leading to many publications on the structure- 
activity relationships and chemical optimizations of analogic structures 
(Gu et al., 2015). Among these are, for example, salicylaldehyde 
hydrazones and analogs, which are capable of inhibiting T3SSs in mul-
tiple pathogenic species of Yersinia, multiple Chlamydias, Salmonella and 
EPEC (Kauppi et al., 2003; Gauthier et al., 2005; Negrea et al., 2007). 
Independently of each other, Kauppi et al. (2003) and Gauthier et al. 
(2005) discovered similar chemical structures capable of inhibiting 
T3SS in Yersinia pseudotuberculosis and EPEC. Kauppi et al. (2003) used a 
whole-cell reporter gene assay to screen 9400 compounds against Yer-
sinia pseudotuberculosis T3SS and Gauthier et al. monitored EspB secre-
tion from the T3SS of EPEC in culture using ELISA against 20,000 
Maybridge compounds. Similarly, Pan et al. (2007) used an avirulent but 
luminant Yersinia pestis to screen 70,966 compounds, finding previously 
recognized compounds but also other ones with entirely new structures. 
Yet another similar high-throughput approach is the absorbance-based 
monitoring of T3SS-dependant red blood cells lysis first described by 
Warawa et al. (Warawa, Finlay, and Kenny 1999). Screening using this 
method has led to the rediscovery of the antibiotics aurodox and fac-
tumycin as down-regulators of the T3SS (Kimura et al., 2011). 
In a similar fashion, our primary objective was to create a high- 
content screening assay for EPEC pedestal formation using a whole- 
cell infection model. Therefore, we designed an automated 
fluorescence-imaging assay in which cell monolayers are infected with 
bacteria, and an infection phenotype is monitored using actin binding 
fluorophores. This assay is an automated, 96-well plate adaptation of the 
EPEC-Caco-2 adherence and fluorescence microscopy assay described by 
Knutton et al. (1989) supplemented with a suitable positive control and 
data reduction method based on extracting actin pedestals from the 
images automatically in high-throughput. 
3.1. Assay design and validation 
Expressing foreign proteins – such as the fluorescent protein we used 
– in pathogens, can change important biological properties of the 
microorganism, in the worst case rendering the entire assay invalid. 
Therefore, we evaluated whether the transformed strain created for the 
assay can cause comparable actin rearrangements on the cells leading to 
similar assay readouts. For this purpose, cells were infected with both 
the wild type EPEC strain, and the transformed fluorescent strain and 
compared. Both strains could adhere to the Caco-2 monolayer in 
microcolonies, infect the cultured cells, and produce similar actin 
polymerization phenotypes and readouts (Supplementary data Figs. S1- 
S2). We also carried out an experiment to evaluate the stability of the 
fluorescent strain in the assay (Supplementary data Figs. S3-S5). The 
results show that on average about 93.7% (CI95% 89.3% - 96.7%) of the 
bacteria can be perceived with fluorescence imaging. A small proportion 
of non-fluorescent bacteria may be present in the assay, although non- 
viable bacteria are lost in washing steps of the assay. However, our 
methodology only uses the fluorescence signal to create a mask for 
downstream processing and this does not require every single bacterium 
to be fluorescent. 
Since several substances have been reported in the literature to be 
capable of preventing EPEC A/E-lesions in in vitro models, we studied if 
they could also prevent actin pedestals in our assay and be used as 
controls. Most of these substances work by perturbing the T3SS in some 
manner (see Table 1). 
Recombinant human lactoferrin did not show any effect on pedestal 
formation (β = − 0.001, p = 0.7, see Fig. 3) according to our results. 
Ochoa et al. reported that lactoferrin prevents actin pedestals “due to 
interference with the initial step in EPEC mammalian cell attachment” 
(Ochoa et al., 2003). This discrepancy may be explained by the fact that 
lactoferrin does not decrease the proportion of colonies with pedestals 
but does decrease the absolute counts of actin pedestals by preventing 
the initial attachment to cell monolayers. Ochoa et al. analyzed actin 
pedestals in HEp2 monolayers by counting the HEp2 cells as positive for 
actin pedestals if they had microcolonies of at least ten bacteria and 
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associated actin pedestals as evaluated by eye. They do not therefore 
address the issue of whether the microcolonies present display lesser 
relative degree of pedestal formation or not. 
We noticed, additionally, that lactoferrin at 5.0 μg mL− 1 did not 
decrease the total amount of bacteria present in the images, but rather it 
increased microcolony counts (230% compared to the non-treated 
control, Supplementary data Fig. S6) while decreasing microcolony 
average areas by 36% (Supplementary data Fig. S6). In contrast, com-
pounds purely detrimental to microcolony formation – such as 10% 
DMSO – similarly decrease average sizes, but they also decrease total 
microcolony counts (Supplementary data Fig. S6). Interestingly micro-
colony sizes display a very uneven Pareto or exponential degree distri-
bution, where the large majority have small sizes while a few colonies 
have large sizes. Indeed, this is what one would expect if bacterial ag-
gregation to colonies displays preferential attachment and can be 
modelled with the Barabási–Albert model as most biological network 
phenomena can (Barabási, 2009; Grinberg et al., 2019). In other words, 
a new adhering or forming bacterium is likelier to appear in a colony 
with more members than into a small one. In any case, this also means 
that counting colonies above a certain size – such as that in the work of 
Ochoa et al. – will exclude more of the microcolonies in the lactoferrin 
condition than in other conditions not affecting the size. Thus, it is 
possible to see an increase in total microcolony counts, while simulta-
neously seeing a decrease in cells positive for actin pedestals. Ochoa 
et al. also used a four-hour incubation time and much higher MOI 
(1:500) than used in this work. Due to lactoferrin’s capacity to change 
the localized adherence phenotype, the assay we describe here can be 
used to probe the effects of library compounds on microcolony forma-
tion using 5.0 mg mL− 1 lactoferrin as a control. 
A peptide (YFPYSHTSPRQP) reported to be capable of preventing 
localized adherence – an early attachment phenotype of some EPEC 
strains (Li et al., 2016) – resulted in no measurable decrease in the 
number of actin pedestals (β = 0.0002, p = 0.19, see Fig. 3). Neither did 
it have any effect on EPEC microcolony size nor counts (Supplementary 
data Fig. S6). Li et al. used a much shorter infection time (30 min) and 
did not analyze pedestals, but only adhesion. 
Genistein, a kinase inhibitor used as a control in many assays 
involving actin rearranging pathogens (Coconnier et al., 1998; Rose-
nshine et al., 1996) was capable of preventing actin pedestals in our 
assay (β = − 0.002 p = 0.04, see Fig. 3). There was, however, consid-
erable variation between experiments, which perhaps are not due to 
properties inherent to genistein, but rather further optimization would 
be needed. The duration between pipetting the suspensions and the plate 
reaching the incubator likely needs to be very precise, since the effect of 
genistein is known to be enhanced by short pretreatment of the cells 
before infection. However, as genistein is a promiscuous kinase blocker 
with multiple other inhibiting effects on normal cell signaling, it also 
interferes with the normal biology of the host cell to some degree. 
Aurodox – an antibiotic produced by Streptomyces goldniensis (Maehr 
et al., 1973, 1979) – is a member of the elfamycin family of antibiotics 
first described in the 1970’s (Maehr et al., 1973). It was rediscovered as 
a T3SS inhibitor in 2011, in a screening campaign utilizing natural 
product libraries (Kimura et al., 2011). The exact mechanism of action of 
aurodox is not entirely understood, but like other antimicrobial sub-
stances extracted from Streptomyces, it inhibits protein biosynthesis, 
although through an elongation factor (Tu), and not by directly inhib-
iting ribosome activity (Parmeggiani and Swart, 1985; Vogeley et al., 
2001). This down-regulates the transcription of T3SS-related genes in 
the locus of enterocyte effacement (LEE) via the repression of a master 
regulator (ler) (Elliott et al., 2000). These genes are known to be 
necessary for the induction of actin pedestals in in vitro organ culture 
(Cepeda-Molero et al., 2017). In our assay we pretreated bacteria with 
aurodox due to its translation-mediated mechanism of action. Aurodox 
both decreased the quantity of perceivable pedestals (β = − 0.076, p <
0.001, see Fig. 3) and their density suggesting that it partially prevented 
actin condensation underneath the colonies. Aurodox at concentration 
of 5.0 μg mL− 1 was used in earlier high-throughput assays (Kimura et al., 
2011) and it only slightly inhibited the growth of the transformed bac-
teria (Supplementary data Fig. S7). We therefore chose aurodox at 5.0 
μg mL− 1 concentration as positive control for further assay validation 
steps. 
Most screening library compounds are stored and delivered in 
DMSO. The ability of Caco-2 cells to tolerate DMSO concentrations up to 
10% without substantial membrane damage or changes in apical 
membrane permeability has been reported in the literature (Da Violante 
et al., 2002). Therefore, we conducted an experiment to assess the 
tolerance of the assay to DMSO at 1–10% of the total volume. DMSO 
concentration did not significantly alter the readout, but at 
Fig. 3. The effects of positive control can-
didates on the proportion of colonies with 
pedestals in the assay. The peptide 
(YFPYSHTSPRQP) did not show any dose- 
dependent effect, lactoferrin had no effect 
on the readout, except that the intercept was 
slightly lower, due to it inhibiting normal 
colony formation. Genistein and aurodox 
displayed a dose-dependent decrease in the 
assay readout, though genistein demon-
strated large between experiment variation. 
Data points represent means of five fields of 
view from three individual wells from three 
independent experiments performed on 
distinct days. The non-treated control (MEM 
only) is indicated in each panel as a grey line 
and a ribbon indicates the 95% confidence 
interval of the mean.   
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concentrations above 5% cell detachment increased lowering the values 
and causing increased variation (Supplementary data Fig. S8). However, 
total fluorescence emitted by bacteria decreased in a concentration- 
dependent manner (Supplementary data Fig. S9) suggesting possible 
toxicity or degradation of the fluorescent protein. Thus, total DMSO 
concentrations in this assay should not exceed 5% of total well volume. 
In order to assess assay stability over different plates and days, we 
ran nine assay plates – three separate plates on three separate days – and 
analyzed the data following procedure and the acceptance criteria 
described in the assay guidance manual (Iversen et al., 2004). The re-
sults show a consistent signal over different plate regions (Fig. 4). There 
were no considerable between-plates differences, nor any difference 
over the distinct days; all within-day and between-day fold shifts were 
below two. There was also low variance between wells, the intraplate 
coefficients of variance being under 0.2 for the primary readout on 
average, while the signal windows (SW) were above 2 for all plates. 
We calculated the Z’-factors on the pedestal counts as this data is on a 
scale that is more suitable for Z’ than a bound proportion of counts 
(Iversen et al., 2006; Sui and Wu, 2007). Z’ was designed for traditional 
HTS readouts and is not so well suited for imaging assays (Iversen et al., 
2004). On average our assay scored a Z’-factor of 0.44 with four pro-
duction assay replicates and has a σmax/σmin of 1.0. This is equivalent to 
a T80% ≥ 50 of 56.1, meaning that at a cut-off for hit selection of 56% 
inhibition this assay will recognize 76.7% of all compounds truly 
inhibiting at more than 50%, while only 20% of the compounds iden-
tified as active will not truly inhibit by more than 50% (Bar and Zwei-
fach, 2020). However, the level of required replicates can be decreased 
by either using higher concentration of aurodox as a control or 
increasing the cut-off level to proclaim a compound active. 
In order to be able to automatically screen the images, we designed 
an image analysis pipeline written in Python, in which we counted the 
amounts of pedestals in the field of view. Because Caco-2 cells display 
congenital structures rich in actin, processing fluorescent actin staining 
images via mere segmentation is not optimal for this complex assay set- 
up. Since the relevant actin rich pedestal structures are located under-
neath adherent bacteria, we processed the images by using the bacterial 
signal as a mask on the actin image. This process focuses the analysis on 
a very small part of the entire image (a region of interest, depicted in 
Fig. 2C), thus making it more specific and less prone to include false 
positives compared to simple segmentation from the actin channel, 
while remaining computationally light. At times the regions of interest 
may contain other actin rich structures not related to bacteria, or that 
are present over the entire segment with higher signal than that caused 
by the pedestal. To deal with this issue, we added a third step where the 
captured segments were validated by allowing only those with concur-
rent mCherry signal. This for the most part avoids capturing actin rich 
areas that are not related to bacteria and allows to achieve an adequate 
assay signal window. 
Additionally, the total fluorescence intensity signal window from 
minimum to maximum, from the actin staining was measured as an 
indicator of the density of the actin condensation at that region. This was 
done because our control substances were capable of not only decreasing 
the count of pedestals, but also their total density, and such a number 
gives a means to estimate qualitative degradation of the pedestal 
structures in a production screen, in addition to simply enumerating 
them. This is particularly important, as there might exist library com-
pounds that interfere with the condensation in multiple distinct ways. 
Data extracted from the multiple fields of view were then aggregated 
by calculating their arithmetic mean. We tested the effect of using 
multiple fields of view on both the error of the estimate and on the 
variation between wells, by calculating the standard error of the mean 
and assay variability related parameters from data derived from one 
field of view, then adding additional fields of view until the results 
converge. As expected, increasing the number of fields of view used for 
the estimate decreases the level of error with diminishing returns 
(Table 2). The average standard error of the mean for the main readout 
Fig. 4. Assay reproducibility over distinct 
plates and on various days. The plot shows 
results from three full 96-well plates on three 
distinct days (total of nine plates). The assay 
was performed by dispensing a maximal 
concentration (5.0 μg mL− 1) of the positive 
control aurodox, a lower concentration (2.5 
μg mL− 1), and non-treated control (all with 
8 × 4 = 32 wells) at varying locations on the 
plate, following guidelines of the Assay 
Guidance Manual (Sittampalam et al., 2004). 
Each data point represents an average mea-
surement of five fields of view from one well.   
T. Pylkkö et al.                                                                                                                                                                                                                                  
Journal of Microbiological Methods 184 (2021) 106201
8
decreased from 3.8 to 2.5 when moving from a mean of two fields of 
view to one of five, but the increment was smaller after each addition to 
the point that the last addition barely showed improvement (Supple-
mentary data Fig. S10). The improved well-level estimate then 
decreased the between-well variation in such a manner that the SW and 
Z’-factor increased from 3.28 and 0.4 to 4.35 and 0.47, respectively. 
With five fields of view, the within-well coefficients of variation (CV) for 
the main readout were below 0.2 (Supplementary data Fig. S11). 
3.2. Assay application areas 
Above we discussed other whole-cell screening methods used to 
screen for T3SS inhibitors. While these do use whole-cell setups and wild 
type strains, they either do not model an actual infection of mammalian 
cells or analyze fairly crude endpoints, such as cell death or lysis. Our 
method is based on the monitoring of the phenotypic changes in the 
actin cytoskeleton, and therefore allows following the pathological 
changes to actin polymerization, in particular, in the case of some EPEC 
strains and their associated actin pedestals. In contrast to target-based 
assays, this phenotypic assay potentially allows to identify compounds 
interfering with a variety of target molecules involved in eliciting actin 
pedestals. In addition, pathogens may cause abnormal actin polymeri-
zation recognizable in images but nevertheless be incapable of red blood 
cell lysis or other effector-based damage to cells. Additionally, this assay 
can be used to monitor the earlier stages of EPEC adherence via 
following colony morphology and could be used to screen inhibitors of 
localized adherence and autoaggregation (Hyland et al., 2006). Obvi-
ously, however, imaging and the respective data analysis require 
specialized equipment and is more laborious. A limitation of our 
approach is that not all clinical EPEC isolates show actin polymerization 
in this assay in vitro (Knutton et al., 2001; Knutton et al., 1991). Such 
strains may nevertheless be pathogenic and cause A/E lesions in vivo 
(Rocha et al., 2011). One challenge of designing the assay was the se-
lection of a positive control substance. Many substances are used in the 
literature for assays dealing with actin modulating pathogens or, alter-
natively, are known to prevent effector injection via the T3SS. Not all of 
them, however, are readily available or capable of creating a robust 
dose-dependent response via specific, non-lethal, effects preferably on 
the bacteria alone. While aurodox certainly can prevent actin pedestals, 
the bacteria need to be pretreated before-hand due to the translation- 
mediated mechanism of action. In most screening settings this is not, 
however, something that can be reasonably done when screening 
extensive numbers of compounds, and one is then restricted to searching 
for compounds of more rapid manners of inhibition. 
Given that multiple pathogens cause A/E lesions or use other cyto-
skeletal manipulation, it might be possible to extend the assay described 
here to study these other pathogens (Stradal and Schelhaas, 2018). 
Pathogens capable of causing the A/E-lesion phenotype and associated 
actin pedestals include enteropathogenic Escherichia coli, enter-
ohemorrhagic Escherichia coli (EHEC), Escherichia albertii, a murine 
specific strain Citrobacter rodentium, and rabbit enteropathogenic 
Escherichia coli (Yamamoto et al., 2017). EHEC strains, for example, also 
cause pedestals in cultured cells, although according to Knutton et al., 
they do not all attach to Caco-2 cells. The authors, however, also re-
ported that EHEC strains of serotypes 0157:H7 and 026:H11 do adhere 
to Hep-2 and HEL cell monolayers, suggesting that these might be 
reasonable alternative host cells (Knutton et al., 1989). Various other 
abnormal actin accumulation phenotypes are described in the literature 
(Stevens et al., 2006). For example, “comet tails” created by Listeria, 
Rickettsia, Bulkholderia, (Ambrosi et al., 2012; Jasnin et al., 2013; Val-
vano et al., 2005) “ruffles” by Salmonella (Francis et al., 1993), and 
expanding the image analysis and classification algorithms to distin-
guish these phenotypes is possible. While aurodox, which is used here as 
a positive control, may not be suitable for use with other pathogens, 
salicylaldehyde hydrazones (Negrea et al., 2007) or actin polymeriza-
tion disruptors, like cytochalasin D (Sanger et al., 1996) or tyrosine ki-
nase inhibitors (staurosporine, genistein)(Benjamin et al., 1995), and 
possibly many more substances, can be substituted if needed. 
3.3. Conclusions 
Here we report the optimization and validation of HTS-compatible 
high-content imaging assay for screening for compounds inhibiting 
pathogen-induced actin pedestals. The method is based on a fluorescent 
EPEC strain accompanied by actin staining and therefore can be used for 
detecting molecules targeting effectors inducing actin pedestals in EPEC 
infection. With some modifications, this assay could be amended for 
studying other actin-modulating pathogens. The assay can be performed 
in 96-well format therefore enhancing the discovery of new anti-
virulence compounds. 
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